nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.106	0.229	CbGbCtD
Vinblastine—ABCB1—Lisinopril—systemic scleroderma	0.0585	0.127	CbGbCtD
Vinblastine—ABCC1—Methotrexate—systemic scleroderma	0.0573	0.124	CbGbCtD
Vinblastine—ABCB1—Captopril—systemic scleroderma	0.0438	0.0948	CbGbCtD
Vinblastine—ABCC2—Methotrexate—systemic scleroderma	0.0424	0.0918	CbGbCtD
Vinblastine—CYP2D6—Captopril—systemic scleroderma	0.0413	0.0893	CbGbCtD
Vinblastine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0345	0.0746	CbGbCtD
Vinblastine—ABCB1—Prednisone—systemic scleroderma	0.0276	0.0596	CbGbCtD
Vinblastine—ABCC6—dermis—systemic scleroderma	0.0239	0.125	CbGeAlD
Vinblastine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0207	0.0447	CbGbCtD
Vinblastine—CYP3A4—Prednisone—systemic scleroderma	0.0165	0.0357	CbGbCtD
Vinblastine—ABCB1—Methotrexate—systemic scleroderma	0.0138	0.0299	CbGbCtD
Vinblastine—JUN—artery—systemic scleroderma	0.00724	0.0379	CbGeAlD
Vinblastine—JUN—endothelium—systemic scleroderma	0.00611	0.032	CbGeAlD
Vinblastine—JUN—blood vessel—systemic scleroderma	0.00564	0.0296	CbGeAlD
Vinblastine—TUBG1—smooth muscle tissue—systemic scleroderma	0.00461	0.0242	CbGeAlD
Vinblastine—TUBG1—skin of body—systemic scleroderma	0.00455	0.0239	CbGeAlD
Vinblastine—TUBD1—digestive system—systemic scleroderma	0.00434	0.0227	CbGeAlD
Vinblastine—TUBD1—tendon—systemic scleroderma	0.00413	0.0216	CbGeAlD
Vinblastine—TUBB3—connective tissue—systemic scleroderma	0.0041	0.0215	CbGeAlD
Vinblastine—TUBE1—digestive system—systemic scleroderma	0.00407	0.0213	CbGeAlD
Vinblastine—TUBE1—tendon—systemic scleroderma	0.00387	0.0203	CbGeAlD
Vinblastine—TUBG1—digestive system—systemic scleroderma	0.00364	0.0191	CbGeAlD
Vinblastine—TUBD1—lung—systemic scleroderma	0.00362	0.019	CbGeAlD
Vinblastine—TUBG1—tendon—systemic scleroderma	0.00346	0.0182	CbGeAlD
Vinblastine—ABCC6—connective tissue—systemic scleroderma	0.00345	0.0181	CbGeAlD
Vinblastine—JUN—Integrin-linked kinase signaling—GIT2—systemic scleroderma	0.00343	0.041	CbGpPWpGaD
Vinblastine—TUBE1—lung—systemic scleroderma	0.0034	0.0178	CbGeAlD
Vinblastine—TUBG1—lung—systemic scleroderma	0.00304	0.0159	CbGeAlD
Vinblastine—TUBB3—digestive system—systemic scleroderma	0.00296	0.0155	CbGeAlD
Vinblastine—TUBA1A—connective tissue—systemic scleroderma	0.00292	0.0153	CbGeAlD
Vinblastine—JUN—connective tissue—systemic scleroderma	0.00289	0.0152	CbGeAlD
Vinblastine—JUN—Signaling events mediated by focal adhesion kinase—GIT2—systemic scleroderma	0.00269	0.0321	CbGpPWpGaD
Vinblastine—TUBA1A—smooth muscle tissue—systemic scleroderma	0.00267	0.014	CbGeAlD
Vinblastine—JUN—smooth muscle tissue—systemic scleroderma	0.00264	0.0139	CbGeAlD
Vinblastine—TUBA1A—skin of body—systemic scleroderma	0.00264	0.0138	CbGeAlD
Vinblastine—JUN—skin of body—systemic scleroderma	0.00261	0.0137	CbGeAlD
Vinblastine—TUBB4A—connective tissue—systemic scleroderma	0.00249	0.0131	CbGeAlD
Vinblastine—TUBB3—lung—systemic scleroderma	0.00247	0.013	CbGeAlD
Vinblastine—TUBA1A—p73 transcription factor network—GDF15—systemic scleroderma	0.00246	0.0294	CbGpPWpGaD
Vinblastine—TUBB2B—connective tissue—systemic scleroderma	0.00241	0.0126	CbGeAlD
Vinblastine—TUBB2A—connective tissue—systemic scleroderma	0.00227	0.0119	CbGeAlD
Vinblastine—TUBB4A—skin of body—systemic scleroderma	0.00225	0.0118	CbGeAlD
Vinblastine—ABCB11—digestive system—systemic scleroderma	0.00223	0.0117	CbGeAlD
Vinblastine—TUBA1A—digestive system—systemic scleroderma	0.00211	0.0111	CbGeAlD
Vinblastine—JUN—digestive system—systemic scleroderma	0.00209	0.0109	CbGeAlD
Vinblastine—TUBB—smooth muscle tissue—systemic scleroderma	0.00209	0.0109	CbGeAlD
Vinblastine—ABCC6—lung—systemic scleroderma	0.00208	0.0109	CbGeAlD
Vinblastine—TUBB2A—smooth muscle tissue—systemic scleroderma	0.00208	0.0109	CbGeAlD
Vinblastine—TUBB2A—skin of body—systemic scleroderma	0.00205	0.0107	CbGeAlD
Vinblastine—TUBB6—smooth muscle tissue—systemic scleroderma	0.00205	0.0107	CbGeAlD
Vinblastine—TUBB6—skin of body—systemic scleroderma	0.00202	0.0106	CbGeAlD
Vinblastine—JUN—Dexamethasone—Mometasone—systemic scleroderma	0.00201	0.324	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Mometasone—systemic scleroderma	0.00201	0.324	CbGdCrCtD
Vinblastine—TUBA1A—tendon—systemic scleroderma	0.00201	0.0105	CbGeAlD
Vinblastine—JUN—tendon—systemic scleroderma	0.00199	0.0104	CbGeAlD
Vinblastine—TUBB4B—connective tissue—systemic scleroderma	0.00195	0.0102	CbGeAlD
Vinblastine—TUBB4A—digestive system—systemic scleroderma	0.0018	0.00944	CbGeAlD
Vinblastine—SLC22A2—digestive system—systemic scleroderma	0.00179	0.0094	CbGeAlD
Vinblastine—TUBB4B—smooth muscle tissue—systemic scleroderma	0.00178	0.00933	CbGeAlD
Vinblastine—TUBA1A—lung—systemic scleroderma	0.00176	0.00923	CbGeAlD
Vinblastine—TUBB4B—skin of body—systemic scleroderma	0.00176	0.00921	CbGeAlD
Vinblastine—JUN—lung—systemic scleroderma	0.00174	0.00914	CbGeAlD
Vinblastine—TUBB2B—digestive system—systemic scleroderma	0.00174	0.00913	CbGeAlD
Vinblastine—TUBB4A—tendon—systemic scleroderma	0.00171	0.00899	CbGeAlD
Vinblastine—TUBB2B—tendon—systemic scleroderma	0.00166	0.00869	CbGeAlD
Vinblastine—TUBB2A—digestive system—systemic scleroderma	0.00164	0.00859	CbGeAlD
Vinblastine—TUBB6—digestive system—systemic scleroderma	0.00162	0.00847	CbGeAlD
Vinblastine—TUBB—tendon—systemic scleroderma	0.00157	0.00822	CbGeAlD
Vinblastine—TUBB2A—tendon—systemic scleroderma	0.00156	0.00818	CbGeAlD
Vinblastine—TUBB6—tendon—systemic scleroderma	0.00154	0.00806	CbGeAlD
Vinblastine—TUBB4A—lung—systemic scleroderma	0.0015	0.00789	CbGeAlD
Vinblastine—JUN—IL12 signaling mediated by STAT4—CD247—systemic scleroderma	0.00147	0.0176	CbGpPWpGaD
Vinblastine—TUBB2B—lung—systemic scleroderma	0.00145	0.00762	CbGeAlD
Vinblastine—TUBG1—Cell Cycle, Mitotic—CENPC—systemic scleroderma	0.00144	0.0172	CbGpPWpGaD
Vinblastine—TUBB4B—digestive system—systemic scleroderma	0.00141	0.00737	CbGeAlD
Vinblastine—JUN—TGF-beta Receptor Signaling—SMAD7—systemic scleroderma	0.00139	0.0166	CbGpPWpGaD
Vinblastine—JUN—IL12 signaling mediated by STAT4—IL13—systemic scleroderma	0.00139	0.0166	CbGpPWpGaD
Vinblastine—TUBB—lung—systemic scleroderma	0.00138	0.00721	CbGeAlD
Vinblastine—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—systemic scleroderma	0.00137	0.0164	CbGpPWpGaD
Vinblastine—TUBB2A—lung—systemic scleroderma	0.00137	0.00718	CbGeAlD
Vinblastine—TUBB6—lung—systemic scleroderma	0.00135	0.00708	CbGeAlD
Vinblastine—TUBB4B—tendon—systemic scleroderma	0.00134	0.00701	CbGeAlD
Vinblastine—JUN—IL12 signaling mediated by STAT4—STAT4—systemic scleroderma	0.00129	0.0155	CbGpPWpGaD
Vinblastine—TUBG1—Cell Cycle—CENPC—systemic scleroderma	0.00129	0.0154	CbGpPWpGaD
Vinblastine—JUN—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—systemic scleroderma	0.00122	0.0146	CbGpPWpGaD
Vinblastine—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.0012	0.00469	CcSEcCtD
Vinblastine—Cerebrovascular accident—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00467	CcSEcCtD
Vinblastine—Agranulocytosis—Azathioprine—systemic scleroderma	0.00119	0.00463	CcSEcCtD
Vinblastine—JUN—CD40/CD40L signaling—TNFAIP3—systemic scleroderma	0.00119	0.0142	CbGpPWpGaD
Vinblastine—Neuropathy peripheral—Leflunomide—systemic scleroderma	0.00118	0.00459	CcSEcCtD
Vinblastine—TUBB4B—lung—systemic scleroderma	0.00117	0.00615	CbGeAlD
Vinblastine—Anorexia—Pentoxifylline—systemic scleroderma	0.00117	0.00456	CcSEcCtD
Vinblastine—Alopecia—Captopril—systemic scleroderma	0.00116	0.00451	CcSEcCtD
Vinblastine—Haemoglobin—Azathioprine—systemic scleroderma	0.00115	0.00448	CcSEcCtD
Vinblastine—Haemorrhage—Azathioprine—systemic scleroderma	0.00115	0.00446	CcSEcCtD
Vinblastine—ABCC2—digestive system—systemic scleroderma	0.00114	0.00596	CbGeAlD
Vinblastine—Angina pectoris—Lisinopril—systemic scleroderma	0.00113	0.0044	CcSEcCtD
Vinblastine—Neuropathy peripheral—Mycophenolic acid—systemic scleroderma	0.00113	0.00438	CcSEcCtD
Vinblastine—Agranulocytosis—Leflunomide—systemic scleroderma	0.00112	0.00437	CcSEcCtD
Vinblastine—ABCB1—blood vessel—systemic scleroderma	0.0011	0.00578	CbGeAlD
Vinblastine—Pancytopenia—Lisinopril—systemic scleroderma	0.0011	0.00429	CcSEcCtD
Vinblastine—JUN—Betamethasone—Prednisone—systemic scleroderma	0.0011	0.176	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Prednisone—systemic scleroderma	0.0011	0.176	CbGdCrCtD
Vinblastine—Haemoglobin—Leflunomide—systemic scleroderma	0.00109	0.00423	CcSEcCtD
Vinblastine—Haemorrhage—Leflunomide—systemic scleroderma	0.00108	0.00421	CcSEcCtD
Vinblastine—ABCC2—tendon—systemic scleroderma	0.00108	0.00567	CbGeAlD
Vinblastine—Pharyngitis—Leflunomide—systemic scleroderma	0.00107	0.00418	CcSEcCtD
Vinblastine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00107	0.00417	CcSEcCtD
Vinblastine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00107	0.00416	CcSEcCtD
Vinblastine—Ill-defined disorder—Captopril—systemic scleroderma	0.00106	0.00412	CcSEcCtD
Vinblastine—Anaemia—Captopril—systemic scleroderma	0.00106	0.00411	CcSEcCtD
Vinblastine—Extravasation—Methotrexate—systemic scleroderma	0.00105	0.0041	CcSEcCtD
Vinblastine—Constipation—Pentoxifylline—systemic scleroderma	0.00105	0.00409	CcSEcCtD
Vinblastine—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.00104	0.00403	CcSEcCtD
Vinblastine—Depression—Lisinopril—systemic scleroderma	0.00103	0.00402	CcSEcCtD
Vinblastine—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.00103	0.00401	CcSEcCtD
Vinblastine—Malaise—Captopril—systemic scleroderma	0.00103	0.00401	CcSEcCtD
Vinblastine—Hypoaesthesia—Mycophenolic acid—systemic scleroderma	0.00103	0.00399	CcSEcCtD
Vinblastine—Pharyngitis—Mycophenolic acid—systemic scleroderma	0.00102	0.00398	CcSEcCtD
Vinblastine—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.00102	0.00397	CcSEcCtD
Vinblastine—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.00101	0.00395	CcSEcCtD
Vinblastine—Myocardial infarction—Lisinopril—systemic scleroderma	0.00101	0.00395	CcSEcCtD
Vinblastine—JUN—Physiological and Pathological Hypertrophy  of the Heart—EDN1—systemic scleroderma	0.00101	0.0121	CbGpPWpGaD
Vinblastine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00101	0.00394	CcSEcCtD
Vinblastine—Alopecia—Azathioprine—systemic scleroderma	0.00101	0.00394	CcSEcCtD
Vinblastine—Anorexia—Mometasone—systemic scleroderma	0.00101	0.00394	CcSEcCtD
Vinblastine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00101	0.00391	CcSEcCtD
Vinblastine—JUN—Regulation of nuclear SMAD2/3 signaling—SMAD7—systemic scleroderma	0.001	0.012	CbGpPWpGaD
Vinblastine—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.000991	0.00386	CcSEcCtD
Vinblastine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000972	0.00378	CcSEcCtD
Vinblastine—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.000966	0.00376	CcSEcCtD
Vinblastine—Agranulocytosis—Lisinopril—systemic scleroderma	0.000966	0.00376	CcSEcCtD
Vinblastine—Discomfort—Captopril—systemic scleroderma	0.000961	0.00374	CcSEcCtD
Vinblastine—Alopecia—Leflunomide—systemic scleroderma	0.000956	0.00372	CcSEcCtD
Vinblastine—Paraesthesia—Mometasone—systemic scleroderma	0.000953	0.00371	CcSEcCtD
Vinblastine—ABCC1—tendon—systemic scleroderma	0.000953	0.00499	CbGeAlD
Vinblastine—Ill-defined disorder—Azathioprine—systemic scleroderma	0.000925	0.0036	CcSEcCtD
Vinblastine—Decreased appetite—Mometasone—systemic scleroderma	0.000923	0.00359	CcSEcCtD
Vinblastine—Pharyngitis—Lisinopril—systemic scleroderma	0.000922	0.00359	CcSEcCtD
Vinblastine—Anaemia—Azathioprine—systemic scleroderma	0.000921	0.00358	CcSEcCtD
Vinblastine—TUBG1—Cell Cycle, Mitotic—CENPA—systemic scleroderma	0.000915	0.0109	CbGpPWpGaD
Vinblastine—Thrombocytopenia—Captopril—systemic scleroderma	0.000913	0.00355	CcSEcCtD
Vinblastine—Alopecia—Mycophenolic acid—systemic scleroderma	0.000912	0.00355	CcSEcCtD
Vinblastine—Pain—Mometasone—systemic scleroderma	0.000908	0.00353	CcSEcCtD
Vinblastine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000906	0.00353	CcSEcCtD
Vinblastine—Depression—Mycophenolate mofetil—systemic scleroderma	0.000904	0.00352	CcSEcCtD
Vinblastine—Malaise—Azathioprine—systemic scleroderma	0.000899	0.0035	CcSEcCtD
Vinblastine—JUN—Endothelins—COL1A2—systemic scleroderma	0.000894	0.0107	CbGpPWpGaD
Vinblastine—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.000894	0.00348	CcSEcCtD
Vinblastine—Leukopenia—Azathioprine—systemic scleroderma	0.000892	0.00347	CcSEcCtD
Vinblastine—JUN—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic scleroderma	0.00089	0.0106	CbGpPWpGaD
Vinblastine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.000889	0.00346	CcSEcCtD
Vinblastine—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.000889	0.00346	CcSEcCtD
Vinblastine—Anorexia—Captopril—systemic scleroderma	0.000889	0.00346	CcSEcCtD
Vinblastine—Asthenia—Pentoxifylline—systemic scleroderma	0.000883	0.00343	CcSEcCtD
Vinblastine—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000874	0.0034	CcSEcCtD
Vinblastine—Anaemia—Leflunomide—systemic scleroderma	0.00087	0.00339	CcSEcCtD
Vinblastine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000868	0.00338	CcSEcCtD
Vinblastine—Malaise—Leflunomide—systemic scleroderma	0.000849	0.0033	CcSEcCtD
Vinblastine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000846	0.00329	CcSEcCtD
Vinblastine—Vertigo—Leflunomide—systemic scleroderma	0.000846	0.00329	CcSEcCtD
Vinblastine—Leukopenia—Leflunomide—systemic scleroderma	0.000843	0.00328	CcSEcCtD
Vinblastine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000842	0.00327	CcSEcCtD
Vinblastine—Abdominal pain—Mometasone—systemic scleroderma	0.000839	0.00326	CcSEcCtD
Vinblastine—Discomfort—Azathioprine—systemic scleroderma	0.000839	0.00326	CcSEcCtD
Vinblastine—Paraesthesia—Captopril—systemic scleroderma	0.000837	0.00326	CcSEcCtD
Vinblastine—ABCC1—lung—systemic scleroderma	0.000836	0.00438	CbGeAlD
Vinblastine—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000833	0.00324	CcSEcCtD
Vinblastine—Neoplasm—Methotrexate—systemic scleroderma	0.00083	0.00323	CcSEcCtD
Vinblastine—Anaemia—Mycophenolic acid—systemic scleroderma	0.00083	0.00323	CcSEcCtD
Vinblastine—JUN—BCR signaling pathway—CSK—systemic scleroderma	0.000822	0.00983	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—COL1A2—systemic scleroderma	0.000822	0.00983	CbGpPWpGaD
Vinblastine—Alopecia—Lisinopril—systemic scleroderma	0.000821	0.00319	CcSEcCtD
Vinblastine—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000818	0.00318	CcSEcCtD
Vinblastine—TUBG1—Cell Cycle—CENPA—systemic scleroderma	0.000818	0.00978	CbGpPWpGaD
Vinblastine—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000814	0.00317	CcSEcCtD
Vinblastine—Dizziness—Pentoxifylline—systemic scleroderma	0.000813	0.00316	CcSEcCtD
Vinblastine—Hypertension—Leflunomide—systemic scleroderma	0.000813	0.00316	CcSEcCtD
Vinblastine—Decreased appetite—Captopril—systemic scleroderma	0.00081	0.00315	CcSEcCtD
Vinblastine—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00081	0.00315	CcSEcCtD
Vinblastine—Malaise—Mycophenolic acid—systemic scleroderma	0.00081	0.00315	CcSEcCtD
Vinblastine—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.000808	0.00314	CcSEcCtD
Vinblastine—Vertigo—Mycophenolic acid—systemic scleroderma	0.000807	0.00314	CcSEcCtD
Vinblastine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000804	0.00313	CcSEcCtD
Vinblastine—Constipation—Captopril—systemic scleroderma	0.000797	0.0031	CcSEcCtD
Vinblastine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000797	0.0031	CcSEcCtD
Vinblastine—Discomfort—Leflunomide—systemic scleroderma	0.000792	0.00308	CcSEcCtD
Vinblastine—JUN—IL1-mediated signaling events—IL1A—systemic scleroderma	0.000788	0.00943	CbGpPWpGaD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—CD247—systemic scleroderma	0.000782	0.00936	CbGpPWpGaD
Vinblastine—Vomiting—Pentoxifylline—systemic scleroderma	0.000782	0.00304	CcSEcCtD
Vinblastine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000778	0.00303	CcSEcCtD
Vinblastine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000775	0.00302	CcSEcCtD
Vinblastine—Headache—Pentoxifylline—systemic scleroderma	0.000771	0.003	CcSEcCtD
Vinblastine—Feeling abnormal—Captopril—systemic scleroderma	0.000768	0.00299	CcSEcCtD
Vinblastine—NR5A1—Generic Transcription Pathway—SMAD7—systemic scleroderma	0.000766	0.00915	CbGpPWpGaD
Vinblastine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000762	0.00297	CcSEcCtD
Vinblastine—Asthenia—Mometasone—systemic scleroderma	0.000762	0.00296	CcSEcCtD
Vinblastine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000755	0.00294	CcSEcCtD
Vinblastine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000752	0.00293	CcSEcCtD
Vinblastine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000751	0.00292	CcSEcCtD
Vinblastine—JUN—CD40/CD40L signaling—CD40LG—systemic scleroderma	0.000749	0.00895	CbGpPWpGaD
Vinblastine—Anaemia—Lisinopril—systemic scleroderma	0.000748	0.00291	CcSEcCtD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic scleroderma	0.00074	0.00885	CbGpPWpGaD
Vinblastine—Abdominal pain—Captopril—systemic scleroderma	0.000737	0.00287	CcSEcCtD
Vinblastine—Anorexia—Leflunomide—systemic scleroderma	0.000732	0.00285	CcSEcCtD
Vinblastine—JUN—Regulation of nuclear SMAD2/3 signaling—COL1A2—systemic scleroderma	0.000731	0.00875	CbGpPWpGaD
Vinblastine—Nausea—Pentoxifylline—systemic scleroderma	0.000731	0.00284	CcSEcCtD
Vinblastine—Malaise—Lisinopril—systemic scleroderma	0.00073	0.00284	CcSEcCtD
Vinblastine—Vertigo—Lisinopril—systemic scleroderma	0.000727	0.00283	CcSEcCtD
Vinblastine—Diarrhoea—Mometasone—systemic scleroderma	0.000726	0.00283	CcSEcCtD
Vinblastine—JUN—Direct p53 effectors—GDF15—systemic scleroderma	0.000726	0.00868	CbGpPWpGaD
Vinblastine—Leukopenia—Lisinopril—systemic scleroderma	0.000724	0.00282	CcSEcCtD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—CENPC—systemic scleroderma	0.00072	0.00861	CbGpPWpGaD
Vinblastine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000719	0.0028	CcSEcCtD
Vinblastine—JUN—Androgen receptor signaling pathway—RHOB—systemic scleroderma	0.000719	0.0086	CbGpPWpGaD
Vinblastine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000718	0.00279	CcSEcCtD
Vinblastine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000699	0.00272	CcSEcCtD
Vinblastine—Paraesthesia—Leflunomide—systemic scleroderma	0.00069	0.00268	CcSEcCtD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—STAT4—systemic scleroderma	0.000689	0.00824	CbGpPWpGaD
Vinblastine—Discomfort—Lisinopril—systemic scleroderma	0.00068	0.00265	CcSEcCtD
Vinblastine—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.00068	0.00265	CcSEcCtD
Vinblastine—JUN—TGF-beta Signaling Pathway—SMAD7—systemic scleroderma	0.000678	0.00811	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—IRF5—systemic scleroderma	0.000675	0.00807	CbGpPWpGaD
Vinblastine—Vomiting—Mometasone—systemic scleroderma	0.000675	0.00263	CcSEcCtD
Vinblastine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00067	0.00261	CcSEcCtD
Vinblastine—Asthenia—Captopril—systemic scleroderma	0.000669	0.0026	CcSEcCtD
Vinblastine—Decreased appetite—Leflunomide—systemic scleroderma	0.000668	0.0026	CcSEcCtD
Vinblastine—JUN—FAS pathway and Stress induction of HSP regulation—IL1A—systemic scleroderma	0.000666	0.00796	CbGpPWpGaD
Vinblastine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000665	0.00259	CcSEcCtD
Vinblastine—Headache—Mometasone—systemic scleroderma	0.000665	0.00259	CcSEcCtD
Vinblastine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000658	0.00256	CcSEcCtD
Vinblastine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000658	0.00256	CcSEcCtD
Vinblastine—Constipation—Leflunomide—systemic scleroderma	0.000657	0.00256	CcSEcCtD
Vinblastine—Pain—Leflunomide—systemic scleroderma	0.000657	0.00256	CcSEcCtD
Vinblastine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000655	0.00255	CcSEcCtD
Vinblastine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000646	0.00251	CcSEcCtD
Vinblastine—TUBA1A—Cell Cycle—CENPC—systemic scleroderma	0.000644	0.0077	CbGpPWpGaD
Vinblastine—Abdominal pain—Azathioprine—systemic scleroderma	0.000643	0.0025	CcSEcCtD
Vinblastine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000639	0.00249	CcSEcCtD
Vinblastine—Diarrhoea—Captopril—systemic scleroderma	0.000638	0.00248	CcSEcCtD
Vinblastine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000637	0.00248	CcSEcCtD
Vinblastine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000637	0.00248	CcSEcCtD
Vinblastine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000634	0.00247	CcSEcCtD
Vinblastine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000633	0.00246	CcSEcCtD
Vinblastine—Nausea—Mometasone—systemic scleroderma	0.00063	0.00245	CcSEcCtD
Vinblastine—Anorexia—Lisinopril—systemic scleroderma	0.000629	0.00245	CcSEcCtD
Vinblastine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000628	0.00244	CcSEcCtD
Vinblastine—Pain—Mycophenolic acid—systemic scleroderma	0.000627	0.00244	CcSEcCtD
Vinblastine—Constipation—Mycophenolic acid—systemic scleroderma	0.000627	0.00244	CcSEcCtD
Vinblastine—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—systemic scleroderma	0.000623	0.00745	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—IL13—systemic scleroderma	0.00062	0.00741	CbGpPWpGaD
Vinblastine—Dizziness—Captopril—systemic scleroderma	0.000616	0.0024	CcSEcCtD
Vinblastine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000614	0.00239	CcSEcCtD
Vinblastine—Depression—Prednisone—systemic scleroderma	0.000613	0.00238	CcSEcCtD
Vinblastine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000612	0.00238	CcSEcCtD
Vinblastine—JUN—TCR Signaling Pathway—CD247—systemic scleroderma	0.000611	0.0073	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—SMAD7—systemic scleroderma	0.000609	0.00728	CbGpPWpGaD
Vinblastine—Abdominal pain—Leflunomide—systemic scleroderma	0.000607	0.00236	CcSEcCtD
Vinblastine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000606	0.00236	CcSEcCtD
Vinblastine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000604	0.00235	CcSEcCtD
Vinblastine—Myocardial infarction—Prednisone—systemic scleroderma	0.000603	0.00234	CcSEcCtD
Vinblastine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000603	0.00234	CcSEcCtD
Vinblastine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000599	0.00233	CcSEcCtD
Vinblastine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000599	0.00233	CcSEcCtD
Vinblastine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000596	0.00232	CcSEcCtD
Vinblastine—Paraesthesia—Lisinopril—systemic scleroderma	0.000593	0.00231	CcSEcCtD
Vinblastine—Vomiting—Captopril—systemic scleroderma	0.000593	0.00231	CcSEcCtD
Vinblastine—Headache—Captopril—systemic scleroderma	0.000584	0.00227	CcSEcCtD
Vinblastine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000579	0.00225	CcSEcCtD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—IRF5—systemic scleroderma	0.000578	0.00691	CbGpPWpGaD
Vinblastine—CYP3A4—digestive system—systemic scleroderma	0.000577	0.00303	CbGeAlD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.000576	0.00689	CbGpPWpGaD
Vinblastine—Decreased appetite—Lisinopril—systemic scleroderma	0.000574	0.00223	CcSEcCtD
Vinblastine—TUBB—Cell Cycle, Mitotic—CENPC—systemic scleroderma	0.000574	0.00686	CbGpPWpGaD
Vinblastine—CYP2D6—digestive system—systemic scleroderma	0.000568	0.00298	CbGeAlD
Vinblastine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000566	0.0022	CcSEcCtD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000566	0.00677	CbGpPWpGaD
Vinblastine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000566	0.0022	CcSEcCtD
Vinblastine—JUN—Senescence and Autophagy in Cancer—IRF5—systemic scleroderma	0.000565	0.00675	CbGpPWpGaD
Vinblastine—Pain—Lisinopril—systemic scleroderma	0.000565	0.0022	CcSEcCtD
Vinblastine—Constipation—Lisinopril—systemic scleroderma	0.000565	0.0022	CcSEcCtD
Vinblastine—JUN—TNF alpha Signaling Pathway—TNFAIP3—systemic scleroderma	0.000562	0.00672	CbGpPWpGaD
Vinblastine—JUN—Apoptosis Modulation and Signaling—BLK—systemic scleroderma	0.00056	0.0067	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—RHOB—systemic scleroderma	0.000557	0.00667	CbGpPWpGaD
Vinblastine—Diarrhoea—Azathioprine—systemic scleroderma	0.000557	0.00217	CcSEcCtD
Vinblastine—JUN—Osteopontin-mediated events—MMP2—systemic scleroderma	0.000555	0.00664	CbGpPWpGaD
Vinblastine—Haemoglobin—Prednisone—systemic scleroderma	0.000555	0.00216	CcSEcCtD
Vinblastine—Nausea—Captopril—systemic scleroderma	0.000554	0.00215	CcSEcCtD
Vinblastine—Haemorrhage—Prednisone—systemic scleroderma	0.000552	0.00215	CcSEcCtD
Vinblastine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000551	0.00215	CcSEcCtD
Vinblastine—Asthenia—Leflunomide—systemic scleroderma	0.000551	0.00214	CcSEcCtD
Vinblastine—Pancytopenia—Methotrexate—systemic scleroderma	0.000547	0.00213	CcSEcCtD
Vinblastine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000544	0.00212	CcSEcCtD
Vinblastine—JUN—Circadian rythm related genes—TOP1—systemic scleroderma	0.000544	0.0065	CbGpPWpGaD
Vinblastine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00054	0.0021	CcSEcCtD
Vinblastine—Dizziness—Azathioprine—systemic scleroderma	0.000538	0.00209	CcSEcCtD
Vinblastine—JUN—IL-1 signaling pathway—IL1A—systemic scleroderma	0.000537	0.00642	CbGpPWpGaD
Vinblastine—JUN—B Cell Receptor Signaling Pathway—BLK—systemic scleroderma	0.000532	0.00636	CbGpPWpGaD
Vinblastine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000526	0.00205	CcSEcCtD
Vinblastine—Diarrhoea—Leflunomide—systemic scleroderma	0.000526	0.00205	CcSEcCtD
Vinblastine—Abdominal pain—Lisinopril—systemic scleroderma	0.000522	0.00203	CcSEcCtD
Vinblastine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000519	0.00202	CcSEcCtD
Vinblastine—Vomiting—Azathioprine—systemic scleroderma	0.000517	0.00201	CcSEcCtD
Vinblastine—TUBB—Cell Cycle—CENPC—systemic scleroderma	0.000513	0.00613	CbGpPWpGaD
Vinblastine—Depression—Methotrexate—systemic scleroderma	0.000512	0.00199	CcSEcCtD
Vinblastine—Headache—Azathioprine—systemic scleroderma	0.00051	0.00198	CcSEcCtD
Vinblastine—Dizziness—Leflunomide—systemic scleroderma	0.000508	0.00198	CcSEcCtD
Vinblastine—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—systemic scleroderma	0.000507	0.00606	CbGpPWpGaD
Vinblastine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000503	0.00196	CcSEcCtD
Vinblastine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000502	0.00195	CcSEcCtD
Vinblastine—JUN—PDGFR-beta signaling pathway—CSK—systemic scleroderma	0.000499	0.00597	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—COL1A2—systemic scleroderma	0.000495	0.00592	CbGpPWpGaD
Vinblastine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000495	0.00192	CcSEcCtD
Vinblastine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000495	0.00192	CcSEcCtD
Vinblastine—Vomiting—Leflunomide—systemic scleroderma	0.000489	0.0019	CcSEcCtD
Vinblastine—Alopecia—Prednisone—systemic scleroderma	0.000488	0.0019	CcSEcCtD
Vinblastine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000486	0.00189	CcSEcCtD
Vinblastine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000485	0.00189	CcSEcCtD
Vinblastine—JUN—Endothelins—EDN1—systemic scleroderma	0.000484	0.00579	CbGpPWpGaD
Vinblastine—Nausea—Azathioprine—systemic scleroderma	0.000483	0.00188	CcSEcCtD
Vinblastine—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—systemic scleroderma	0.000482	0.00576	CbGpPWpGaD
Vinblastine—Headache—Leflunomide—systemic scleroderma	0.000481	0.00187	CcSEcCtD
Vinblastine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000479	0.00187	CcSEcCtD
Vinblastine—JUN—Toll Like Receptor 4 (TLR4) Cascade—ITGAM—systemic scleroderma	0.000479	0.00572	CbGpPWpGaD
Vinblastine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000477	0.00185	CcSEcCtD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—CENPC—systemic scleroderma	0.000475	0.00568	CbGpPWpGaD
Vinblastine—Asthenia—Lisinopril—systemic scleroderma	0.000474	0.00184	CcSEcCtD
Vinblastine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000473	0.00184	CcSEcCtD
Vinblastine—JUN—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000467	0.00558	CbGpPWpGaD
Vinblastine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000466	0.00181	CcSEcCtD
Vinblastine—Haemoglobin—Methotrexate—systemic scleroderma	0.000464	0.0018	CcSEcCtD
Vinblastine—Haemorrhage—Methotrexate—systemic scleroderma	0.000461	0.00179	CcSEcCtD
Vinblastine—Headache—Mycophenolic acid—systemic scleroderma	0.000459	0.00179	CcSEcCtD
Vinblastine—JUN—TWEAK Signaling Pathway—CCL2—systemic scleroderma	0.000458	0.00547	CbGpPWpGaD
Vinblastine—Pharyngitis—Methotrexate—systemic scleroderma	0.000458	0.00178	CcSEcCtD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—CENPA—systemic scleroderma	0.000457	0.00547	CbGpPWpGaD
Vinblastine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000457	0.00178	CcSEcCtD
Vinblastine—Nausea—Leflunomide—systemic scleroderma	0.000456	0.00178	CcSEcCtD
Vinblastine—Diarrhoea—Lisinopril—systemic scleroderma	0.000452	0.00176	CcSEcCtD
Vinblastine—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—systemic scleroderma	0.000452	0.0054	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.000451	0.00539	CbGpPWpGaD
Vinblastine—JUN—Direct p53 effectors—IRF5—systemic scleroderma	0.000449	0.00536	CbGpPWpGaD
Vinblastine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000446	0.00173	CcSEcCtD
Vinblastine—JUN—AP-1 transcription factor network—EDN1—systemic scleroderma	0.000445	0.00532	CbGpPWpGaD
Vinblastine—Anaemia—Prednisone—systemic scleroderma	0.000444	0.00173	CcSEcCtD
Vinblastine—Dizziness—Lisinopril—systemic scleroderma	0.000437	0.0017	CcSEcCtD
Vinblastine—Nausea—Mycophenolic acid—systemic scleroderma	0.000435	0.00169	CcSEcCtD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—CENPC—systemic scleroderma	0.000435	0.0052	CbGpPWpGaD
Vinblastine—JUN—PDGFR-beta signaling pathway—BLK—systemic scleroderma	0.000434	0.00519	CbGpPWpGaD
Vinblastine—Malaise—Prednisone—systemic scleroderma	0.000433	0.00169	CcSEcCtD
Vinblastine—Vertigo—Prednisone—systemic scleroderma	0.000432	0.00168	CcSEcCtD
Vinblastine—JUN—Toll-Like Receptors Cascades—ITGAM—systemic scleroderma	0.000426	0.0051	CbGpPWpGaD
Vinblastine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000426	0.00166	CcSEcCtD
Vinblastine—TUBB4A—Cell Cycle—CENPC—systemic scleroderma	0.000425	0.00508	CbGpPWpGaD
Vinblastine—NR5A1—Generic Transcription Pathway—CTGF—systemic scleroderma	0.000423	0.00506	CbGpPWpGaD
Vinblastine—Vomiting—Lisinopril—systemic scleroderma	0.00042	0.00163	CcSEcCtD
Vinblastine—JUN—Osteopontin-mediated events—MMP9—systemic scleroderma	0.000417	0.00499	CbGpPWpGaD
Vinblastine—Convulsion—Prednisone—systemic scleroderma	0.000416	0.00162	CcSEcCtD
Vinblastine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000415	0.00161	CcSEcCtD
Vinblastine—Hypertension—Prednisone—systemic scleroderma	0.000415	0.00161	CcSEcCtD
Vinblastine—Headache—Lisinopril—systemic scleroderma	0.000414	0.00161	CcSEcCtD
Vinblastine—JUN—IL1-mediated signaling events—IL1B—systemic scleroderma	0.000411	0.00492	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—CENPA—systemic scleroderma	0.000409	0.00489	CbGpPWpGaD
Vinblastine—ABCB1—digestive system—systemic scleroderma	0.000409	0.00214	CbGeAlD
Vinblastine—Alopecia—Methotrexate—systemic scleroderma	0.000408	0.00159	CcSEcCtD
Vinblastine—JUN—Endothelins—MMP1—systemic scleroderma	0.000407	0.00487	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—CSK—systemic scleroderma	0.000406	0.00485	CbGpPWpGaD
Vinblastine—Discomfort—Prednisone—systemic scleroderma	0.000404	0.00157	CcSEcCtD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000404	0.00483	CbGpPWpGaD
Vinblastine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000396	0.00154	CcSEcCtD
Vinblastine—Nausea—Lisinopril—systemic scleroderma	0.000392	0.00153	CcSEcCtD
Vinblastine—JUN—Focal Adhesion—RHOB—systemic scleroderma	0.000392	0.00469	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—CENPC—systemic scleroderma	0.000389	0.00465	CbGpPWpGaD
Vinblastine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00149	CcSEcCtD
Vinblastine—JUN—AP-1 transcription factor network—MMP1—systemic scleroderma	0.000374	0.00447	CbGpPWpGaD
Vinblastine—Anorexia—Prednisone—systemic scleroderma	0.000374	0.00145	CcSEcCtD
Vinblastine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000373	0.00145	CcSEcCtD
Vinblastine—Anaemia—Methotrexate—systemic scleroderma	0.000371	0.00144	CcSEcCtD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.00037	0.00443	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—COL1A2—systemic scleroderma	0.00037	0.00442	CbGpPWpGaD
Vinblastine—JUN—IL-1 signaling pathway—CCL2—systemic scleroderma	0.000369	0.00441	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—SMAD7—systemic scleroderma	0.000369	0.00441	CbGpPWpGaD
Vinblastine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000368	0.00143	CcSEcCtD
Vinblastine—TUBB—Cell Cycle, Mitotic—CENPA—systemic scleroderma	0.000364	0.00436	CbGpPWpGaD
Vinblastine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000362	0.00141	CcSEcCtD
Vinblastine—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—systemic scleroderma	0.000362	0.00433	CbGpPWpGaD
Vinblastine—Malaise—Methotrexate—systemic scleroderma	0.000362	0.00141	CcSEcCtD
Vinblastine—JUN—TCR Signaling Pathway—IL1A—systemic scleroderma	0.000362	0.00433	CbGpPWpGaD
Vinblastine—Vertigo—Methotrexate—systemic scleroderma	0.000361	0.0014	CcSEcCtD
Vinblastine—Leukopenia—Methotrexate—systemic scleroderma	0.000359	0.0014	CcSEcCtD
Vinblastine—JUN—IL12 signaling mediated by STAT4—TGFB1—systemic scleroderma	0.000353	0.00422	CbGpPWpGaD
Vinblastine—Paraesthesia—Prednisone—systemic scleroderma	0.000352	0.00137	CcSEcCtD
Vinblastine—Convulsion—Methotrexate—systemic scleroderma	0.000348	0.00135	CcSEcCtD
Vinblastine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00134	CcSEcCtD
Vinblastine—NR5A1—Gene Expression—TNFSF13—systemic scleroderma	0.000343	0.0041	CbGpPWpGaD
Vinblastine—ABCB1—lung—systemic scleroderma	0.000341	0.00179	CbGeAlD
Vinblastine—Decreased appetite—Prednisone—systemic scleroderma	0.000341	0.00133	CcSEcCtD
Vinblastine—Discomfort—Methotrexate—systemic scleroderma	0.000338	0.00131	CcSEcCtD
Vinblastine—JUN—Focal Adhesion—ITGAM—systemic scleroderma	0.000336	0.00402	CbGpPWpGaD
Vinblastine—Constipation—Prednisone—systemic scleroderma	0.000335	0.0013	CcSEcCtD
Vinblastine—CYP2D6—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.000333	0.00399	CbGpPWpGaD
Vinblastine—JUN—ATF-2 transcription factor network—MMP2—systemic scleroderma	0.000332	0.00397	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—MMP1—systemic scleroderma	0.00033	0.00394	CbGpPWpGaD
Vinblastine—JUN—TWEAK Signaling Pathway—MMP9—systemic scleroderma	0.000327	0.00391	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—CENPA—systemic scleroderma	0.000326	0.0039	CbGpPWpGaD
Vinblastine—Feeling abnormal—Prednisone—systemic scleroderma	0.000323	0.00126	CcSEcCtD
Vinblastine—JUN—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000323	0.00386	CbGpPWpGaD
Vinblastine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000321	0.00125	CcSEcCtD
Vinblastine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000321	0.00125	CcSEcCtD
Vinblastine—JUN—Senescence-Associated Secretory Phenotype (SASP)—IL1A—systemic scleroderma	0.00032	0.00383	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—IL1A—systemic scleroderma	0.00032	0.00383	CbGpPWpGaD
Vinblastine—Anorexia—Methotrexate—systemic scleroderma	0.000312	0.00122	CcSEcCtD
Vinblastine—JUN—LPA receptor mediated events—MMP2—systemic scleroderma	0.000311	0.00372	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—BLK—systemic scleroderma	0.000311	0.00372	CbGpPWpGaD
Vinblastine—Abdominal pain—Prednisone—systemic scleroderma	0.00031	0.00121	CcSEcCtD
Vinblastine—JUN—AP-1 transcription factor network—CCL2—systemic scleroderma	0.000304	0.00364	CbGpPWpGaD
Vinblastine—JUN—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000303	0.00363	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—CENPA—systemic scleroderma	0.000302	0.00361	CbGpPWpGaD
Vinblastine—Paraesthesia—Methotrexate—systemic scleroderma	0.000294	0.00114	CcSEcCtD
Vinblastine—Hypersensitivity—Prednisone—systemic scleroderma	0.000289	0.00112	CcSEcCtD
Vinblastine—Decreased appetite—Methotrexate—systemic scleroderma	0.000285	0.00111	CcSEcCtD
Vinblastine—JUN—AGE/RAGE pathway—NOS3—systemic scleroderma	0.000284	0.0034	CbGpPWpGaD
Vinblastine—Asthenia—Prednisone—systemic scleroderma	0.000281	0.00109	CcSEcCtD
Vinblastine—Pain—Methotrexate—systemic scleroderma	0.00028	0.00109	CcSEcCtD
Vinblastine—JUN—IL-1 signaling pathway—IL1B—systemic scleroderma	0.00028	0.00335	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—CENPA—systemic scleroderma	0.000276	0.0033	CbGpPWpGaD
Vinblastine—Feeling abnormal—Methotrexate—systemic scleroderma	0.00027	0.00105	CcSEcCtD
Vinblastine—TUBB4A—Cell Cycle—CENPA—systemic scleroderma	0.00027	0.00323	CbGpPWpGaD
Vinblastine—Diarrhoea—Prednisone—systemic scleroderma	0.000268	0.00104	CcSEcCtD
Vinblastine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000268	0.00104	CcSEcCtD
Vinblastine—JUN—FGF signaling pathway—MMP9—systemic scleroderma	0.000268	0.0032	CbGpPWpGaD
Vinblastine—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—systemic scleroderma	0.00026	0.00311	CbGpPWpGaD
Vinblastine—Dizziness—Prednisone—systemic scleroderma	0.000259	0.00101	CcSEcCtD
Vinblastine—Abdominal pain—Methotrexate—systemic scleroderma	0.000259	0.00101	CcSEcCtD
Vinblastine—JUN—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000251	0.003	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL13—systemic scleroderma	0.000251	0.003	CbGpPWpGaD
Vinblastine—Vomiting—Prednisone—systemic scleroderma	0.000249	0.00097	CcSEcCtD
Vinblastine—TUBB4B—Cell Cycle—CENPA—systemic scleroderma	0.000247	0.00295	CbGpPWpGaD
Vinblastine—Headache—Prednisone—systemic scleroderma	0.000246	0.000956	CcSEcCtD
Vinblastine—JUN—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	0.000245	0.00292	CbGpPWpGaD
Vinblastine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000241	0.000939	CcSEcCtD
Vinblastine—JUN—IL-3 Signaling Pathway—TGFB1—systemic scleroderma	0.000239	0.00285	CbGpPWpGaD
Vinblastine—Asthenia—Methotrexate—systemic scleroderma	0.000235	0.000915	CcSEcCtD
Vinblastine—JUN—LPA receptor mediated events—MMP9—systemic scleroderma	0.000234	0.00279	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000233	0.00279	CbGpPWpGaD
Vinblastine—Nausea—Prednisone—systemic scleroderma	0.000233	0.000906	CcSEcCtD
Vinblastine—JUN—AGE/RAGE pathway—MMP9—systemic scleroderma	0.000228	0.00273	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—MMP1—systemic scleroderma	0.000225	0.00269	CbGpPWpGaD
Vinblastine—Diarrhoea—Methotrexate—systemic scleroderma	0.000224	0.000872	CcSEcCtD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.000222	0.00266	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Receptor Signaling—TGFB1—systemic scleroderma	0.000221	0.00264	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—IL1A—systemic scleroderma	0.00022	0.00263	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—MMP9—systemic scleroderma	0.000218	0.0026	CbGpPWpGaD
Vinblastine—Dizziness—Methotrexate—systemic scleroderma	0.000217	0.000843	CcSEcCtD
Vinblastine—Vomiting—Methotrexate—systemic scleroderma	0.000208	0.000811	CcSEcCtD
Vinblastine—Headache—Methotrexate—systemic scleroderma	0.000205	0.000799	CcSEcCtD
Vinblastine—NR5A1—Gene Expression—CTGF—systemic scleroderma	0.000204	0.00244	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—IL1A—systemic scleroderma	0.000202	0.00242	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	0.000202	0.00242	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	0.000202	0.00241	CbGpPWpGaD
Vinblastine—TUBA1A—Metabolism of proteins—ACE—systemic scleroderma	0.000202	0.00241	CbGpPWpGaD
Vinblastine—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic scleroderma	0.000196	0.00234	CbGpPWpGaD
Vinblastine—Nausea—Methotrexate—systemic scleroderma	0.000195	0.000757	CcSEcCtD
Vinblastine—JUN—TCR Signaling Pathway—IL1B—systemic scleroderma	0.000189	0.00226	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—MMP2—systemic scleroderma	0.000185	0.00221	CbGpPWpGaD
Vinblastine—JUN—Regulation of Telomerase—TGFB1—systemic scleroderma	0.000184	0.00219	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000183	0.00219	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—TGFB1—systemic scleroderma	0.000179	0.00214	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	0.000171	0.00204	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000169	0.00202	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—IL1B—systemic scleroderma	0.000167	0.00199	CbGpPWpGaD
Vinblastine—JUN—Direct p53 effectors—MMP2—systemic scleroderma	0.000166	0.00199	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	0.000166	0.00199	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—ACE—systemic scleroderma	0.000162	0.00194	CbGpPWpGaD
Vinblastine—TUBB6—Metabolism of proteins—ACE—systemic scleroderma	0.000162	0.00194	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	0.000158	0.00189	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	0.000157	0.00188	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—ACE—systemic scleroderma	0.000157	0.00187	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—IL1A—systemic scleroderma	0.000153	0.00183	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—ACE—systemic scleroderma	0.000152	0.00181	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—ACE—systemic scleroderma	0.000148	0.00177	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—TGFB1—systemic scleroderma	0.000147	0.00175	CbGpPWpGaD
Vinblastine—JUN—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000144	0.00172	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—MMP9—systemic scleroderma	0.000139	0.00166	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—NOS3—systemic scleroderma	0.000139	0.00166	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—ITGAM—systemic scleroderma	0.000138	0.00165	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CD247—systemic scleroderma	0.000138	0.00165	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	0.000133	0.00159	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—ACE—systemic scleroderma	0.000133	0.00159	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—TGFB1—systemic scleroderma	0.00013	0.00155	CbGpPWpGaD
Vinblastine—TUBA1A—Metabolism of proteins—MMP1—systemic scleroderma	0.000129	0.00155	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—TNFAIP3—systemic scleroderma	0.000129	0.00155	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000128	0.00153	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000127	0.00152	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—TGFB1—systemic scleroderma	0.000126	0.0015	CbGpPWpGaD
Vinblastine—JUN—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000122	0.00146	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—ACE—systemic scleroderma	0.000122	0.00146	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.000122	0.00145	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—TGFB1—systemic scleroderma	0.000115	0.00137	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—IL1B—systemic scleroderma	0.000115	0.00137	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—TGFB1—systemic scleroderma	0.000108	0.00129	CbGpPWpGaD
Vinblastine—TUBA1A—Metabolism of proteins—CCL2—systemic scleroderma	0.000105	0.00126	CbGpPWpGaD
Vinblastine—TUBB6—Metabolism of proteins—MMP1—systemic scleroderma	0.000104	0.00124	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—MMP1—systemic scleroderma	0.000104	0.00124	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—MMP1—systemic scleroderma	0.000101	0.0012	CbGpPWpGaD
Vinblastine—TUBA1A—Metabolism of proteins—MMP2—systemic scleroderma	0.0001	0.0012	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—MMP1—systemic scleroderma	9.73e-05	0.00116	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	9.62e-05	0.00115	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—MMP1—systemic scleroderma	9.52e-05	0.00114	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SMAD7—systemic scleroderma	9.26e-05	0.00111	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—TGFB1—systemic scleroderma	8.9e-05	0.00106	CbGpPWpGaD
Vinblastine—JUN—Immune System—CSK—systemic scleroderma	8.55e-05	0.00102	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—MMP1—systemic scleroderma	8.55e-05	0.00102	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TGFBI—systemic scleroderma	8.47e-05	0.00101	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—CCL2—systemic scleroderma	8.46e-05	0.00101	CbGpPWpGaD
Vinblastine—TUBB6—Metabolism of proteins—CCL2—systemic scleroderma	8.46e-05	0.00101	CbGpPWpGaD
Vinblastine—JUN—Immune System—IRF5—systemic scleroderma	8.42e-05	0.00101	CbGpPWpGaD
Vinblastine—ABCC2—NRF2 pathway—TGFB1—systemic scleroderma	8.32e-05	0.000995	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	8.23e-05	0.000984	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—CCL2—systemic scleroderma	8.17e-05	0.000977	CbGpPWpGaD
Vinblastine—TUBB6—Metabolism of proteins—MMP2—systemic scleroderma	8.05e-05	0.000963	CbGpPWpGaD
Vinblastine—TUBB2B—Metabolism of proteins—MMP2—systemic scleroderma	8.05e-05	0.000963	CbGpPWpGaD
Vinblastine—JUN—Immune System—ITGAM—systemic scleroderma	8.04e-05	0.000962	CbGpPWpGaD
Vinblastine—JUN—Immune System—IRF8—systemic scleroderma	8.04e-05	0.000962	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD247—systemic scleroderma	8.04e-05	0.000962	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	8.03e-05	0.00096	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—CCL2—systemic scleroderma	7.92e-05	0.000947	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SMAD7—systemic scleroderma	7.85e-05	0.000939	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—MMP1—systemic scleroderma	7.82e-05	0.000935	CbGpPWpGaD
Vinblastine—TUBB3—Metabolism of proteins—MMP2—systemic scleroderma	7.78e-05	0.00093	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—CCL2—systemic scleroderma	7.74e-05	0.000926	CbGpPWpGaD
Vinblastine—TUBB2A—Metabolism of proteins—MMP2—systemic scleroderma	7.53e-05	0.000901	CbGpPWpGaD
Vinblastine—JUN—Immune System—TNFAIP3—systemic scleroderma	7.53e-05	0.0009	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—HSPG2—systemic scleroderma	7.53e-05	0.0009	CbGpPWpGaD
Vinblastine—JUN—Immune System—BLK—systemic scleroderma	7.44e-05	0.00089	CbGpPWpGaD
Vinblastine—TUBB1—Metabolism of proteins—MMP2—systemic scleroderma	7.37e-05	0.000881	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—CCL2—systemic scleroderma	6.95e-05	0.000831	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HSPG2—systemic scleroderma	6.75e-05	0.000807	CbGpPWpGaD
Vinblastine—TUBB4A—Metabolism of proteins—MMP2—systemic scleroderma	6.61e-05	0.000791	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CSK—systemic scleroderma	6.52e-05	0.00078	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	6.39e-05	0.000765	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—CCL2—systemic scleroderma	6.36e-05	0.00076	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CD247—systemic scleroderma	6.13e-05	0.000733	CbGpPWpGaD
Vinblastine—JUN—Immune System—CTLA4—systemic scleroderma	6.1e-05	0.000729	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RHOB—systemic scleroderma	6.07e-05	0.000726	CbGpPWpGaD
Vinblastine—TUBB4B—Metabolism of proteins—MMP2—systemic scleroderma	6.05e-05	0.000723	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HSPG2—systemic scleroderma	5.73e-05	0.000685	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CTGF—systemic scleroderma	5.7e-05	0.000682	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—HSPG2—systemic scleroderma	5.65e-05	0.000676	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CSK—systemic scleroderma	5.53e-05	0.000661	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-DQB1—systemic scleroderma	5.02e-05	0.0006	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—HSPG2—systemic scleroderma	4.92e-05	0.000589	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL1A—systemic scleroderma	4.77e-05	0.00057	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD40LG—systemic scleroderma	4.74e-05	0.000567	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CTGF—systemic scleroderma	4.29e-05	0.000512	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CTGF—systemic scleroderma	3.73e-05	0.000446	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	3.16e-05	0.000377	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EDN1—systemic scleroderma	3.1e-05	0.000371	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HSPG2—systemic scleroderma	2.69e-05	0.000322	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HSPG2—systemic scleroderma	2.54e-05	0.000303	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL1B—systemic scleroderma	2.49e-05	0.000297	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—NOS3—systemic scleroderma	2.48e-05	0.000297	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NOS3—systemic scleroderma	2.23e-05	0.000266	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCL2—systemic scleroderma	2.12e-05	0.000253	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CTGF—systemic scleroderma	2.04e-05	0.000244	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CTGF—systemic scleroderma	1.92e-05	0.00023	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NOS3—systemic scleroderma	1.89e-05	0.000226	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—NOS3—systemic scleroderma	1.87e-05	0.000223	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HSPG2—systemic scleroderma	1.66e-05	0.000198	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—NOS3—systemic scleroderma	1.62e-05	0.000194	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MMP9—systemic scleroderma	1.52e-05	0.000181	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TGFB1—systemic scleroderma	1.47e-05	0.000176	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CTGF—systemic scleroderma	1.26e-05	0.00015	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TGFB1—systemic scleroderma	1.25e-05	0.000149	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NOS3—systemic scleroderma	8.87e-06	0.000106	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NOS3—systemic scleroderma	8.36e-06	0.0001	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NOS3—systemic scleroderma	5.47e-06	6.54e-05	CbGpPWpGaD
